MAP1LC3B and Parkinson disease: Herein, we observed that DA and its metaboliets DOPAC and HVA levels, TH and P62, P-PI3K, P-mTOR and P-AKT expression were decreased, and а-syn, Beclin-1, LC3B were significantly increased in the PD mice compared with the control mice.